These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1938526)

  • 41. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
    Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
    Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy.
    Bazan JG; Luxton G; Kozak MM; Anderson EM; Hancock SL; Kapp DS; Kidd EA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):983-91. PubMed ID: 24161422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
    Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mangiacotti MG; Margariti PA; Ferrandina G; Scambia G
    Tumori; 2005; 91(3):215-20. PubMed ID: 16206643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
    Sebag-Montefiore D; Meadows HM; Cunningham D; Plowman PN; Hurman DC; Davidson N; Grieve R; Levine E; Glynne-Jones R
    Radiother Oncol; 2012 Aug; 104(2):155-60. PubMed ID: 22857859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemoradiation therapy and IORT in locally advanced rectal cancer: preliminary results in 36 patients.
    Valentini V; Cellini N; De Santis M; Turriziani A; Sofo L; Ratto C; Doglietto GB; Bellantone R; Crucitti F
    Front Radiat Ther Oncol; 1997; 31():213-6. PubMed ID: 9263825
    [No Abstract]   [Full Text] [Related]  

  • 49. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
    Cohen SJ; Dobelbower R; Lipsitz S; Catalano PJ; Sischy B; Smith TJ; Haller DG;
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1345-50. PubMed ID: 16029791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study.
    Lupi G; Raspagliesi F; Zucali R; Fontanelli R; Paladini D; Kenda R; di Re F
    Cancer; 1996 Apr; 77(8):1472-8. PubMed ID: 8608531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
    Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
    Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
    Stewart FM; Harkins BJ; Hahn SS; Daniel TM
    Cancer; 1989 Aug; 64(3):622-8. PubMed ID: 2501018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
    Weinstein GD; Rich TA; Shumate CR; Skibber JM; Cleary KR; Ajani JA; Ota DM
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):197-204. PubMed ID: 7721616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
    Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
    Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
    Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.
    Kastl S; Brunner T; Herrmann O; Riepl M; Fietkau R; Grabenbauer G; Sauer R; Hohenberger W; Klein P
    Eur J Surg Oncol; 2000 Sep; 26(6):578-82. PubMed ID: 11034809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Initial locoregional chemotherapy in recurrent and locoregional advanced or inoperable stages of pelvic uterine and anorectal cancers].
    Manivit P; Polo R; Tabary D; Nabet M; Polo M; Adamy M; Rubini B; Fromaget JM; Chipponi PN; Untereiner M
    Bull Cancer; 1995 Jan; 82(2):137-48. PubMed ID: 10846531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.